The Christie NHS Foundation Trust: all 100 studies

Page 1 of 1. Open to participants first (25), then studies with results posted, then the rest; newest registration first within each.

• Investigation of the ROle of faT and inflAmmaTory Cells in mElanomaNot yet recruitingNCT07293598
• A Phase III Randomised Control Clinical Trial of Radiotherapy With Radiosensitisation Versus Intravesical Bacillus Calmette-Guerin Therapy for High-risk Non-muscle Invasive Bladder Cancer.Not yet recruitingNCT07268339Phase 3
• Using Red Light Therapy to Ease Skin Side Effects and Mouth Side Effects, in Children and Young People Aged 0 to 16 Years Old, Receiving RadiotherapyNot yet recruitingNCT07183267Not applicable
• To Determine Whether it is Feasible to Treat Patients Requiring Urgent Radiotherapy Diagnosed With Metastatic Cord Compression (MSCC) on the Magnetic Resonance Linear Accelerator (MRL) in a Single Appointment and Compare it to the Standard of Care Radiotherapy PathwayRecruitingNCT06965101Not applicable
• Pencil Beam Scanning Proton Beam Radiotherapy for the Management of Abdominal NeuroblastomaNot yet recruitingNCT06804447Not applicable
• Enabling Genomic Testing in Cancer of Unknown PrimaryRecruitingNCT06695494
• Chronic Radiation Induced Bowel Toxicity StudyRecruitingNCT06640959
• Exploratory Study of EBV DNA Titre Clearance Whilst on Proton Beam TherapyNot yet recruitingNCT06480903
• Circulating Tumour DNA Guided Adaptive BRAF and MEK Inhibitor TherapyNot yet recruitingNCT06470880Phase 2
• Evaluation of Combined Modality Protons and Hepatic Transplantation for Hilar CholangiocarcinomaNot yet recruitingNCT06434493Not applicable
• Investigating the Role of Adjuvant Proton Beam Therapy in Patients With Parotid CarcinomaNot yet recruitingNCT06421649Not applicable
• Preoperative Preradiotherapy TTFieldsRecruitingNCT06136611Not applicable
• Introduction of Y90-PET-CT Post Radioembolisation Therapy ScansRecruitingNCT06123676Not applicable
• The CASCADE ProjectNot yet recruitingNCT06117592
• Assessing the Relationship Between Hypoxia and the Immune Environment in Myeloma Patients (CHIME)Not yet recruitingNCT06007989
• A Feasibility Study of MRI Guided Stereotactic Ablative Radiotherapy (MIDSECTION)RecruitingNCT05903430
• Musculoskeletal Health in Adult Haematological Cancer SurvivorsRecruitingNCT05865678
• The Use and Development of Patient Reported Outcome Measures (PROMs) in the Adoptive Cell Therapy (ACT) SettingRecruitingNCT05721365
• Molecular Characterisation of Colorectal Cancer Peritoneal MetastasesRecruitingNCT05513716
• Molecular Characterisation of Appendiceal CancerRecruitingNCT05364788
• Anorexia iN Cancer Patients: ANCHORRecruitingNCT04791254
• MRI Development for Radiotherapy Planning and Delivery in Non-Patient VolunteersRecruitingNCT04749134
• Tumour Characterisation to Guide Experimental Targeted Therapy - NationalRecruitingNCT04723316
• Serial Tumour Biopsies and Blood Biomarkers in MelanomaRecruitingNCT04493723
• PreOperative Brain Irradiation in GlioblastomaRecruitingNCT03582514Phase 1
• Pragmatic Analysis of Complex Radiotherapy Cases In Cancer of the LungActive, not recruitingNCT07202260
• PatIent exPeRiences and prEFerence of trEatment foR Multiple MyelomaCompletedNCT06322927
• Radial Artery AccessCompletedNCT05768412
• Hypoxia-driven Prostate Cancer Genomics (HYPROGEN)Status unknownNCT05702619
• Feasibility of Utilising Brushing Cytology and Dermoscopy for Diagnosing Penile LesionsStatus unknownNCT05662839Not applicable
• Development and Validation of a Patient Reported Experience Measure for Experimental Cancer MedicineCompletedNCT05386602
• The Psychological Impact of COVID-19 on Patients with Solid Malignancies: a Single-Institution Survey StudyCompletedNCT05359718
• Development of a Patient Reported Outcome Measure for Advanced Ovarian Cancer Patients Receiving Surgical and Chemotherapy TreatmentStatus unknownNCT05274867
• Upper GI Serial Tumour BiopsiesSuspendedNCT05233007
• A Survey Exploring Health and Screening Tests in People Treated for Hodgkin LymphomaCompletedNCT04996862
• Effect of Pelvic Radiotherapy on the Intestinal Microbiome and MetabolomeCompletedNCT04995809
• Lung Screening in People Cured of Hodgkin LymphomaCompletedNCT04986189Not applicable
• NOTION: iN-home Sampling Of cyTokines in ImmunOtherapy patieNtsCompletedNCT04960059
• Circulating Tumour DNA guidEd Therapy for Stage IIB/C mElanoma After surgiCal resecTIONTerminatedNCT04901988Phase 2/3
• COvid-19 aNd TechNology - thE Impact on Clinical Trial PatientsCompletedNCT04852809
• Carcinoma of Unknown Primary (CUP): a Comparison Across Tissue and Liquid BiomarkersCompletedNCT04750109
• Quantification of Abdominal Organ Motion Using MRICompletedNCT04748094
• Personalised Disease Monitoring in Metastatic Breast CancerActive, not recruitingNCT04597580
• COntinuous Signs Monitoring In Covid-19 PatientsCompletedNCT04581031Not applicable
• Bone Toxicity Following Pelvic RadiotherapyActive, not recruitingNCT04555317Not applicable
• Qualitative Exploration of Head & Neck Cancer Patient Reported Experience of RadiotherapyStatus unknownNCT04543045
• Impact on Quality of Life From Multi-modality Lung CancerStatus unknownNCT04540757
• Impact of COVID-19 on Lung Cancer PatientsCompletedNCT04538456
• Remote Monitoring of Cancer Patients With Suspected Covid-19Status unknownNCT04397705Phase 1
• Developing Lung Cancer Screening in Hodgkin Lymphoma Survivors: a Qualitative StudyCompletedNCT04396119
• PDAC Peripheral and Portal Vein SamplingCompletedNCT04289961Not applicable
• The CAPER Trial: A Phase Ib Clinical Trial of Cyclophosphamide And PEmbrolizumab in Metastatic Renal Cell CarcinomaStatus unknownNCT04262427Phase 1/2
• Remote Monitoring of Patients at Risk of SepsisWithdrawnNCT04260230Not applicable
• A Proof of Concept Window Trial of the IMmunological Effects of AveLumab and Aspirin in Triple-Negative Breast CancerWithdrawnNCT04188119Phase 2
• Patient Experience of Consent for Cancer Surgery in Light of Recent Changes to UK Law- a Questionnaire StudyCompletedNCT04024189
• The Goals of Care InitiativeTerminatedNCT04020679Not applicable
• Second-line Therapy for Patients With Progressive Poorly Differentiated Extra-pulmonary Neuroendocrine CarcinomaCompletedNCT03837977Phase 2
• CAcTUS - Circulating Tumour DNA Guided SwitchActive, not recruitingNCT03808441Phase 2
• A Proof of Concept, Window Trial of the IMmunological Effects of AveLumab and Aspirin in Triple-Negative Breast CancerWithdrawnNCT03794596Phase 2
• Irinotecan Drug-eluting Bead Liver Embolisation RegistryStatus unknownNCT03697044
• Pancreatic Cancer Dietary Assessment StudyCompletedNCT03616431
• A Study Using MRI To Assess Bladder Motion During RadiotherapyStatus unknownNCT03409029Not applicable
• A Translational Study Investigating PD-L1 Expression After Radiotherapy for Non-small Cell Lung CancerCompletedNCT03258788
• Respiratory Distress Symptom Intervention (RDSI) TrialCompletedNCT03223805Not applicable
• A Pilot Study Using Magnetic Resonance (MR) to Assess Cervix Motion During Radiotherapy Treatment.CompletedNCT03101306Not applicable
• Magnetic Resonance Imaging (MRI) for the Delineation of Organs At Risk (OAR) and Target Volumes in Lung Cancer PatientsCompletedNCT03048760Not applicable
• Multi-maintenance Olaparib After Disease Recurrence in Participants With Platinum Sensitive BRCAm High Grade Serous Ovarian CancerCompletedNCT02855697Early Phase 1
• A Study to Evaluate a Diary for Patient Reported Outcome Measures (PROMs)CompletedNCT02507804Not applicable
• Study to Determine the Feasibility, Evaluability and Variability in Markers of Drug Action in Castration Resistant Prostate CancerCompletedNCT02424448
• ABC-08: Phase Ib Trial of Acelarin in Combination With Cisplatin in Locally Advanced/ Metastatic Biliary Tract CancersCompletedNCT02351765Phase 1
• Standard Care Alone or With Acupuncture for CIPN in Breast Cancer and Multiple MyelomaCompletedNCT02275403Phase 2
• Study to Determine the Feasibility of Sentinel Node Biopsy in Patients With Anal CancerWithdrawnNCT02162641
• PLX3397 KIT in Acral aNd mucOsal MelanomaCompletedNCT02071940Phase 2
• PAZOFOS: Phase Ib and Phase II Trial of Pazopanib +/- Fosbretabulin in Advanced Recurrent Ovarian CancerTerminatedNCT02055690Phase 1/2
• TIL Therapy in Metastatic Melanoma and IL2 Dose AssessmentTerminatedNCT01995344Phase 2
• MRI in Pre-operative Radiotherapy for Soft Tissue Sarcoma: MISTS StudyCompletedNCT01956019Not applicable
• NIMRAD (A Randomised Placebo-controlled Trial of Synchronous NIMorazole Versus RADiotherapy Alone in Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma Not Suitable for Synchronous Chemotherapy or Cetuximab)CompletedNCT01950689Phase 3
• Active Symptom Control Alone or With mFOLFOX Chemotherapy for Locally Advanced/ Metastatic Biliary Tract CancersCompletedNCT01926236Phase 3
• Development of a Biomarker Directed Strategy to Ameliorate Common Toxicities From Conventional ChemotherapySuspendedNCT01921998
• The Use of Rectal Balloons in Radical Pelvic Radiotherapy - a Feasibility StudyStatus unknownNCT01842750Not applicable
• Phase II Study of Fractionated 90Y Ibritumomab Tiuxetan (Zevalin) Radioimmunotherapy as an Initial Therapy of Follicular LymphomaCompletedNCT01493479Phase 2
• A Phase I Study of CD19 Specific T Cells in CD19 Positive MalignancyTerminatedNCT01493453Phase 1
• Radiotherapy & Olaparib in COmbination for Carcinoma of the OesophagusStatus unknownNCT01460888Phase 1
• Measurement of Gemcitabine Metabolites in Blood and Urine as Predictors of Response to GemX Bladder RadiotherapyCompletedNCT01343121Not applicable
• Erbitux Study of CPT11, Oxaliplatin, UFToral Targeted TherapyCompletedNCT01225744Phase 2
• Window Study of ZD4054 in Metastatic Prostate CancerStatus unknownNCT01168141Not applicable
• Dual REctcal Angiogenesis or MEK Inhibition radioTHERAPY TrialTerminatedNCT01160926Phase 1
• MEK Inhibitor and Thoracic Radiotherapy TrialCompletedNCT01146756Phase 1
• RESPeCT: Revlimid Early Stage Poor Prognosis Chronic Lymphocytic Leukaemia (CLL) TrialTerminatedNCT01127542Phase 2
• Tissue Sample Collection From Patients With Soft Tissue Sarcoma of the Arms, Hands, Legs, or Feet Treated on Clinial Trial CRUK-VORTEXStatus unknownNCT00900211
• Study of DNA Mutations in Predicting the Effect of External-Beam Radiation Therapy in Patients With Early Breast Cancer, Localized Prostate Cancer, or Gynecological CancerStatus unknownNCT00601406Not applicable
• Cetuximab and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed by SurgeryCompletedNCT00599833Phase 2
• Effect of Pegvisomant on GH/IGF-I Relationship in GHDTerminatedNCT00468624Not applicable
• Concurrent Once Daily Versus Twice Daily Radiotherapy for Limited Stage Small Cell Lung CancerCompletedNCT00433563Not applicable
• Hospitalization Rates of Patients With Non-Small Cell Lung Cancer Treated With Gemcitabine and Either Cisplatin or CarboplatinStatus unknownNCT00055965Phase 3
• Combination Chemotherapy in Treating Patients With Metastatic Cancer of an Unknown Site of OriginStatus unknownNCT00022178Phase 3
• Gemcitabine Plus Supportive Care in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung CancerStatus unknownNCT00022009Phase 2/3
• Temozolomide in Treating Women With Advanced Breast CancerStatus unknownNCT00005054Phase 2
• Interleukin-2 With or Without Histamine Dihydrochloride in Treating Patients With Metastatic Kidney CancerStatus unknownNCT00005038Phase 2
• Paclitaxel and Carboplatin Chemotherapy Compared With Standard Chemotherapy in Treating Patients With Stage III or Stage IV Non-small Cell Lung Cancer That Cannot Be Removed During SurgeryStatus unknownNCT00004887Phase 3

← The Christie NHS Foundation Trust overview and focus areas